Renaissance Technologies’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$170K Buy
+106,068
New +$170K ﹤0.01% 3200
2025
Q1
Sell
-130,374
Closed -$246K 3738
2024
Q4
$246K Buy
+130,374
New +$246K ﹤0.01% 3103
2024
Q2
Sell
-17,600
Closed -$210K 3840
2024
Q1
$210K Buy
17,600
+12,329
+234% +$147K ﹤0.01% 3213
2023
Q4
$42K Buy
+5,271
New +$42K ﹤0.01% 3482
2022
Q4
Sell
-2,515
Closed -$61K 4316
2022
Q3
$61K Sell
2,515
-8,055
-76% -$195K ﹤0.01% 3707
2022
Q2
$216K Sell
10,570
-25,890
-71% -$529K ﹤0.01% 3617
2022
Q1
$1.3M Sell
36,460
-21,755
-37% -$774K ﹤0.01% 2546
2021
Q4
$1.58M Buy
58,215
+45,476
+357% +$1.24M ﹤0.01% 2337
2021
Q3
$553K Buy
+12,739
New +$553K ﹤0.01% 2852
2021
Q2
Sell
-41,628
Closed -$1.87M 3691
2021
Q1
$1.87M Buy
41,628
+38,893
+1,422% +$1.75M ﹤0.01% 2275
2020
Q4
$71K Sell
2,735
-2,605
-49% -$67.6K ﹤0.01% 3297
2020
Q3
$77K Buy
+5,340
New +$77K ﹤0.01% 3246
2020
Q1
Sell
-1,970
Closed -$23K 3690
2019
Q4
$23K Buy
+1,970
New +$23K ﹤0.01% 3443
2019
Q2
Sell
-558
Closed -$83K 3709
2019
Q1
$83K Buy
+558
New +$83K ﹤0.01% 3319